Unknown

Dataset Information

0

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.


ABSTRACT: HLA genotype-clinical phenotype correlations are not established for multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). We studied HLA-DRB1/DPB1 genotype-phenotype correlations in 528 MS and 165 NMOSD cases using Japan MS/NMOSD Biobank materials. HLA-DRB1*04:05, DRB1*15:01 and DPB1*03:01 correlated with MS susceptibility and DRB1*01:01, DRB1*09:01, DRB1*13:02 and DPB1*04:01 were protective against MS. HLA-DRB1*15:01 was associated with increased optic neuritis and cerebellar involvement and worsened visual and pyramidal functional scale (FS) scores, resulting in higher progression index values. HLA-DRB1*04:05 was associated with younger onset age, high visual FS scores, and a high tendency to develop optic neuritis. HLA-DPB1*03:01 increased brainstem and cerebellar FS scores. By contrast, HLA-DRB1*01:01 decreased spinal cord involvement and sensory FS scores, HLA-DRB1*09:01 decreased annualized relapse rate, brainstem involvement and bowel and bladder FS scores, and HLA-DRB1*13:02 decreased spinal cord and brainstem involvement. In NMOSD, HLA-DRB1*08:02 and DPB1*05:01 were associated with susceptibility and DRB1*09:01 was protective. Multivariable analysis revealed old onset age, long disease duration, and many relapses as independent disability risks in both MS and NMOSD, and HLA-DRB1*15:01 as an independent risk only in MS. Therefore, both susceptibility and protective alleles can influence the clinical manifestations in MS, while such genotype-phenotype correlations are unclear in NMOSD.

SUBMITTER: Watanabe M 

PROVIDER: S-EPMC7804194 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.

Watanabe Mitsuru M   Nakamura Yuri Y   Sato Shinya S   Niino Masaaki M   Fukaura Hikoaki H   Tanaka Masami M   Ochi Hirofumi H   Kanda Takashi T   Takeshita Yukio Y   Yokota Takanori T   Nishida Yoichiro Y   Matsui Makoto M   Nagayama Shigemi S   Kusunoki Susumu S   Miyamoto Katsuichi K   Mizuno Masanori M   Kawachi Izumi I   Saji Etsuji E   Ohashi Takashi T   Shimohama Shun S   Hisahara Shin S   Nishiyama Kazutoshi K   Iizuka Takahiro T   Nakatsuji Yuji Y   Okuno Tatsusada T   Ochi Kazuhide K   Suzumura Akio A   Yamamoto Ken K   Kawano Yuji Y   Tsuji Shoji S   Hirata Makoto M   Sakate Ryuichi R   Kimura Tomonori T   Shimizu Yuko Y   Nagaishi Akiko A   Okada Kazumasa K   Hayashi Fumie F   Sakoda Ayako A   Masaki Katsuhisa K   Shinoda Koji K   Isobe Noriko N   Matsushita Takuya T   Kira Jun-Ichi JI  

Scientific reports 20210112 1


HLA genotype-clinical phenotype correlations are not established for multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). We studied HLA-DRB1/DPB1 genotype-phenotype correlations in 528 MS and 165 NMOSD cases using Japan MS/NMOSD Biobank materials. HLA-DRB1*04:05, DRB1*15:01 and DPB1*03:01 correlated with MS susceptibility and DRB1*01:01, DRB1*09:01, DRB1*13:02 and DPB1*04:01 were protective against MS. HLA-DRB1*15:01 was associated with increased optic neuritis and cereb  ...[more]

Similar Datasets

| S-EPMC9844421 | biostudies-literature
| S-EPMC7937038 | biostudies-literature
| S-EPMC7187724 | biostudies-literature
| S-EPMC5946009 | biostudies-literature
| S-EPMC8742014 | biostudies-literature
| S-EPMC8315565 | biostudies-literature
| S-EPMC7655447 | biostudies-literature
| S-EPMC5147908 | biostudies-literature
| S-EPMC7794341 | biostudies-literature
| S-EPMC5092160 | biostudies-literature